These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2696637)

  • 1. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.
    Conway JG; Cattley RC; Popp JA; Butterworth BE
    Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS; Cattley RC; Conway JG; Popp JA
    Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation.
    Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD
    Dev Toxicol Environ Sci; 1983; 11():595-8. PubMed ID: 6677511
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years.
    Cattley RC; Conway JG; Popp JA
    Cancer Lett; 1987 Dec; 38(1-2):15-22. PubMed ID: 3690505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Di-n-octyl phthalate (DOP), a relatively ineffective peroxisome inducing straight chain isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of putative preneoplastic lesions in rat liver.
    DeAngelo AB; Garrett CT; Manolukas LA; Yario T
    Toxicology; 1986 Nov; 41(3):279-88. PubMed ID: 2877511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    Jpn J Cancer Res; 1990 Mar; 81(3):213-5. PubMed ID: 2112523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on the carcinogenic potential of di(2-ethylhexyl) phthalate.
    Northup S; Martis L; Ulbricht R; Garber J; Miripol J; Schmitz T
    J Toxicol Environ Health; 1982 Sep; 10(3):493-518. PubMed ID: 7175976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate.
    Popp JA; Garvey LK; Hamm TE; Swenberg JA
    Carcinogenesis; 1985 Jan; 6(1):141-4. PubMed ID: 2857115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats.
    Rao MS; Yeldandi AV; Subbarao V
    J Toxicol Environ Health; 1990 Jun; 30(2):85-9. PubMed ID: 2355402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Di(2-ethylhexyl) phthalate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():269-94. PubMed ID: 6751991
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator.
    Rao MS; Usuda N; Subbarao V; Reddy JK
    Carcinogenesis; 1987 Sep; 8(9):1347-50. PubMed ID: 2887302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing human health risks from exposure to di(2-ethylhexyl)phthalate (DEHP) and related phthalates: scientific issues.
    Schulz CO
    Drug Metab Rev; 1989; 21(1):111-20. PubMed ID: 2696632
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis.
    Popp JA; Garvey LK; Cattley RC
    Toxicol Ind Health; 1987 Jun; 3(2):151-63. PubMed ID: 3303447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
    Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
    Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments.
    Beliles R; Salinas JA; Kluwe WM
    Drug Metab Rev; 1989; 21(1):3-12. PubMed ID: 2696634
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine.
    Hagiwara A; Diwan BA; Ward JM
    Jpn J Cancer Res; 1986 Dec; 77(12):1215-21. PubMed ID: 3102426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome induction studies on seven phthalate esters.
    Barber ED; Astill BD; Moran EJ; Schneider BF; Gray TJ; Lake BG; Evans JG
    Toxicol Ind Health; 1987 Jun; 3(2):7-24. PubMed ID: 3617071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEHP [Di(2-ethylhexyl)phthalate]--risk assessment. The EPA workshop. April 19-20, 1988, Bethesda, Maryland. Proceedings.
    Drug Metab Rev; 1989; 21(1):1-120. PubMed ID: 2625122
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinogenic potential of phthalic acid esters and related compounds: structure-activity relationships.
    Kluwe WM
    Environ Health Perspect; 1986 Mar; 65():271-8. PubMed ID: 3709453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.